Berberine and PCOS

Berberine, ovulation, and fertility outcomes in PCOS

A 2024 meta-analysis of randomized controlled trials examined berberine as an adjuvant therapy in women with PCOS who had reduced fertility potential. Pooling 10 trials and 713 participants, it reported that berberine added to standard Western medicine was associated with a higher ovulation rate than standard medicine alone, alongside improvements in clinical pregnancy rate and endometrial thickness.^[1]

The same analysis reported reductions in luteinizing hormone and total testosterone with berberine as an adjuvant, while follicle-stimulating hormone did not change significantly. These hormonal shifts were proposed as possible contributors to the ovulation findings, but the authors framed the results as needing confirmation in further trials.^{[1], [2]}

Metabolic and insulin-resistance findings

A separate systematic review of clinical trials and randomized controlled trials assessed berberine across several metabolic and hormonal measures in women with PCOS. It reported that berberine was associated with a reduction in insulin resistance, measured as HOMA-IR, as well as a decrease in waist-to-hip ratio and androstenedione.^[2]

That review also found that berberine did not significantly reduce body weight, and that findings on waist circumference and body mass index were conflicting across studies. It likewise reported no significant effect on follicle-stimulating hormone or luteinizing hormone in the trials it examined.^[2]

What the evidence does and does not show

Taken together, the available syntheses suggest berberine may have a role as an adjuvant in PCOS for certain reproductive and metabolic outcomes, but the evidence base is built on trials that differ in design, dosing, and comparison groups. Both the meta-analysis and the systematic review explicitly note that further clinical trials are needed before drawing definitive conclusions.^{[1], [2]}

Limitations of the evidence

Much of the trial data comes from studies where berberine was combined with standard medication rather than used alone, so its independent contribution is hard to isolate. Dosing and trial duration varied, and the abstracts did not report a single pooled dose, so the amount used in any individual study may differ from another.^{[1], [2]}

Findings on some measures, including body weight, waist circumference, and body mass index, were inconsistent, and the authors of both reviews call for additional confirmatory trials. People with PCOS should consult a qualified healthcare professional before making decisions about supplementation; this article is informational only.^{[1], [2]}